[1] |
刘冰.牙源性角化囊肿外科治疗策略[C]//第十四次中国口腔颌面外科学术会议论文集. 重庆, 2018: 49.
|
[2] |
Gorlin RJ, Goltz RW.Multiple nevoid basal-cell epithelioma,jaw cysts and bifid rib[J].N Engl J Med, 1960, 262(18):908-912
|
[3] |
Dos Santos JL, Delgado RZR, de Oliveira GR, et al.Odontogenic keratocysts as first manifestation of nevoid basal cell carcinoma syndrome: surgical management and immunohistochemical analysis[J].J Craniofac Surg, 2018, 29(6):1588-1590
|
[4] |
Seo DU, Kim SG, Oh JS, et al.Treatment of nevoid basal cell carcinoma syndrome: a case report[J].J Korean Assoc Oral Maxillofac Surg, 2016, 42(5):284-287
|
[5] |
Ali IK, Karjodkar FR, Sansare K, et al.Nevoid basal cell carcinoma syndrome - clinical and radiological findings of three cases[J].Cureus, 2016, 8(8):e727-
|
[6] |
Lo Muzio L.Nevoid basal cell carcinoma syndrome (Gorlin syndrome)[J]. Orphanet J Rare Dis, 2008, 3: 32.
|
[7] |
Yasar B, Byers HJ, Smith MJ, et al.Common variants modify the age of onset for basal cell carcinomas in Gorlin syndrome[J].Eur J Hum Genet, 2015, 23(5):708-710
|
[8] |
Kato C, Fujii K, Arai Y, et al.Nevoid basal cell carcinoma syndrome caused by splicing mutations in the PTCH1 gene[J].Fam Cancer, 2017, 16(1):131-138
|
[9] |
Shiohama T, Fujii K, Miyashita T, et al.Brain morphology in children with nevoid basal cell carcinoma syndrome[J].Am J Med Genet A, 2017, 173(4):946-952
|
[10] |
Durmaz CD, Evans G, Smith MJ, et al.A novel PTCH1 frameshift mutation leading to nevoid basal cell carcinoma syndrome[J].Cytogenet Genome Res, 2018, 154(2):57-61
|
[11] |
Sim YC, Kim GH, Choi SW, et al.Novel PTCH1 gene mutation in nevoid basal cell carcinoma syndrome[J].J Craniofac Surg, 2018, 29(3):e252-e255
|
[12] |
Smith MJ, Beetz C, Williams SG, et al.Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations[J].J Clin Oncol, 2014, 32(36):4155-4161
|
[13] |
Athar M, Li CZ, Kim AL, et al.Sonic hedgehog signaling in Basal cell nevus syndrome[J].Cancer Res, 2014, 74(18):4967-4975
|
[14] |
Silapunt S, Chen L, Migden MR.Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness[J].Ther Adv Med Oncol, 2016, 8(5):375-382
|
[15] |
Pino LC, Balassiano LK, Sessim M, et al.Basal cell nevus syndrome: clinical and molecular review and case report[J].Int J Dermatol, 2016, 55(4):367-375
|
[16] |
高第, 黄二顺, 孙婷婷, 等.痣样基底细胞癌综合征一家系基因突变分析[J].中华皮肤科杂志, 2014, 47(12):860-863
|
[17] |
Marsh A, Wicking C, Wainwright B, et al.DHPLC analysis of patients with Nevoid Basal Cell Carcinoma Syndrome reveals novel PTCH missense mutations in the sterol-sensing domain[J].Hum Mutat, 2005, 26(3):283-
|
[18] |
Bresler SC, Padwa BL, Granter SR.Nevoid basal cell carcinoma syndrome (gorlin syndrome)[J].Head Neck Pathol, 2016, 10(2):119-124
|
[19] |
Evans DG, Ladusans EJ, Rimmer S, et al.Complications of the naevoid basal cell carcinoma syndrome: results of a population based study[J].J Med Genet, 1993, 30(6):460-464
|
[20] |
Kimonis VE, Goldstein AM, Pastakia B, et al.Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome[J].Am J Med Genet, 1997, 69(3):299-308
|
[21] |
Qu JF, Yu FY, Hong YY, et al.Underestimated PTCH1 mutation rate in sporadic keratocystic odontogenic tumors[J].Oral Oncol, 2015, 51(1):40-45
|
[22] |
Ponti G, Manfredini M, Pastorino L, et al.PTCH1 germline mutations and the basaloid follicular hamartoma values in the tumor spectrum of basal cell carcinoma syndrome (NBCCS)[J].Anticancer Res, 2018, 38(1):471-476
|
[23] |
Pereira T, Tamgadge A, Sapdhare S, et al.Multiple keratocystic odontogenic tumors in nevoid basal cell carcinoma syndrome[J].Ann Maxillofac Surg, 2015, 5(2):277-280
|